Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats

被引:9
作者
Nagura, J
Yamamoto, M
Hui, C
Yasuda, S
Hachisu, M
Konno, F
机构
[1] Pharmaceutical Research Center, Meiji Seika Kaisha Ltd., Yokohama
[2] Pharmaceutical Research Center, Meiji Seika Kaisha Ltd., Kohoku-ku, Yokohama 222
关键词
angiotensin AT(1) receptor antagonist; hypertensive complications; losartan; ME3221; stroke-prone spontaneously hypertensive rats;
D O I
10.1111/j.1440-1681.1996.tb02601.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. A comparison was made on the protective effects of the following: ME3221, a competitive angiotensin AT(1) receptor antagonist; losartan, in which a major active metabolite is a non-competitive angiotensin AT(1) receptor antagonist; and enalapril, an angiotensin-converting enzyme inhibitor, using the salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). 2. SHRSP received orally ME3221 (3 and 10 mg/kg per day), losartan (10 mg/kg per day) and enalapril (10 mg/kg per day) from the 6th to the 20th week of age. All the control rats showed rapid elevation of systolic blood pressure (SEP), accompanied by hypertensive complications, and died by 15 weeks of age. 3. ME3221, losartan and enalapril suppressed the elevation of SEP in the salt-loaded SHRSP to a comparable degree, ME3221 and losartan increased the survival rate to >90%, and diminished hypertensive complications such as cerebral apoplexy (stroke), renal injury (increased proteinuria, and total N-acetyl-beta-D-glucosaminidase activity) and heart failure (cardiac hypertrophy and pleural effusion). 4. Competitive (ME3221) and non-competitive (losartan) angiotensin AT(1) receptor antagonists showed comparable efficacy against the complications and mortality of the salt-loaded SHRSP; both were more potent than enalapril in the protective effect.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 33 条
  • [1] EFFECTS OF HIGH OR LOW SODIUM INTAKE IN SPONTANEOUSLY HYPERTENSIVE RATS
    AOKI, K
    OKAMOTO, K
    OOSHIMA, A
    YAMORI, Y
    [J]. JAPANESE CIRCULATION JOURNAL, 1972, 36 (06): : 539 - +
  • [2] BAGDON WJ, 1985, JPN PHARMACOL THER, V13, P425
  • [3] ANGIOTENSIN-II EFFECTS UPON GLOMERULAR MICROCIRCULATION AND ULTRAFILTRATION COEFFICIENT OF RAT
    BLANTZ, RC
    KONNEN, KS
    TUCKER, BJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (02) : 419 - 434
  • [4] BROWN JJ, 1963, LANCET, V2, P278
  • [5] RENAL-SPECIFIC ACTIONS OF ANGIOTENSIN-II RECEPTOR ANTAGONISM IN THE ANESTHETIZED DOG
    CHAN, DP
    SANDOK, EK
    AARHUS, LL
    HEUBLEIN, DM
    BURNETT, JC
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (06) : 354 - 360
  • [6] CHRIST D, 1990, 3 N AM ISSX M SAN DI, V34, P21
  • [7] ASYNCHRONOUS CHANGES IN PRORENIN AND RENIN SECRETION AFTER CAPTOPRIL IN PATIENTS WITH RENAL-ARTERY STENOSIS
    DERKX, FHM
    TANTJIONG, L
    WENTING, GJ
    BOOMSMA, F
    TVELD, AJMI
    SCHALEKAMP, MADH
    [J]. HYPERTENSION, 1983, 5 (02) : 244 - 256
  • [8] LOSARTAN PROTECTIVE EFFECTS IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS PERSIST DURABLY AFTER TREATMENT WITHDRAWAL
    FORNES, P
    RICHER, C
    VACHER, E
    BRUNEVAL, P
    GIUDICELLI, JF
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (02) : 305 - 313
  • [9] EFFECT OF SODIUM-INTAKE ON BIOSYNTHESIS OF RENIN
    IWAO, H
    MICHELAKIS, AM
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (05): : 506 - 511
  • [10] Kawano Kenichi, 1994, Japanese Journal of Pharmacology, V64, p331P